| Home > In process > lncRNA Glelr modulates microglia inflammatory programs in association with PU.1. |
| Journal Article | DZNE-2026-00385 |
; ; ; ; ; ; ; ; ; ;
2026
Elsevier
[Amsterdam]
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.nbd.2026.107366
Abstract: Long non-coding RNAs (lncRNAs) are emerging as key regulators of brain function, but their contribution to microglial aging and neurodegenerative disease remains largely unknown. Because only 1.5% of the human genome encodes proteins, whereas the vast majority of transcripts belong to the largely unexplored non-coding RNAome, elucidating the functions of non-coding RNAs provides an unprecedented opportunity to expand the space for therapeutic discovery. We recently identified the glia-enriched lncRNA Glelr as upregulated in the aging mouse hippocampus. Here, we investigated its function in microglia and its human homolog GLELR. We found that Glelr/GLELR is expressed in both astrocytes and microglia and increases with age. Knockdown of Glelr in primary microglia led to enhanced expression of pro-inflammatory cytokines, including TNFα, and increased phagocytic activity. RNA-sequencing revealed widespread transcriptional changes enriched for TNF and complement signaling pathways. The human homolog GLELR showed conserved functions in iPSC-derived microglia, where its loss similarly promoted inflammatory gene expression and phagocytosis. Mechanistically, Glelr interacts with the microglial transcription factor PU.1, and its depletion overlapped with PU.1-driven transcriptional programs. Consistent with these findings, GLELR expression was significantly reduced in postmortem Alzheimer's disease (AD) brains, and AD-associated genes were enriched among Glelr-regulated targets. Together, our results identify Glelr/GLELR as a conserved, aging-associated lncRNA that modulates microglial inflammatory states through interaction with PU.1. This work links glial lncRNA regulation to AD-related neuroinflammation and suggests GLELR as a potential molecular target to fine-tune microglial activity in neurodegenerative diseases.
Keyword(s): RNA, Long Noncoding: metabolism (MeSH) ; RNA, Long Noncoding: genetics (MeSH) ; Microglia: metabolism (MeSH) ; Animals (MeSH) ; Humans (MeSH) ; Mice (MeSH) ; Trans-Activators: metabolism (MeSH) ; Trans-Activators: genetics (MeSH) ; Proto-Oncogene Proteins: metabolism (MeSH) ; Proto-Oncogene Proteins: genetics (MeSH) ; Inflammation: metabolism (MeSH) ; Inflammation: genetics (MeSH) ; Mice, Inbred C57BL (MeSH) ; Cells, Cultured (MeSH) ; Aging: metabolism (MeSH) ; Astrocytes: metabolism (MeSH) ; 3222401L13Rik/ENSG00000272070 ; Alzheimer's disease ; Long non-coding RNA (lncRNA) ; Microglia ; Neuroinflammation ; Non-coding RNAome ; PU.1 (SPI1) ; RNA, Long Noncoding ; Trans-Activators ; Proto-Oncogene Proteins